Mi‐Hyeon You

1.0k total citations
21 papers, 569 citations indexed

About

Mi‐Hyeon You is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mi‐Hyeon You has authored 21 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mi‐Hyeon You's work include Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Veterinary Oncology Research (4 papers). Mi‐Hyeon You is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Veterinary Oncology Research (4 papers). Mi‐Hyeon You collaborates with scholars based in South Korea, United States and Ethiopia. Mi‐Hyeon You's co-authors include Byeong Mo Kim, Tae Ho Lee, Dae-Yong Kim, Chun-Hau Chen, Keesung Kim, Andre Levchenko, Deok‐Ho Kim, Kahp-Yang Suh, Moon K. Kwak and Won Gu Kim and has published in prestigious journals such as Scientific Reports, Journal of Neurochemistry and Human Molecular Genetics.

In The Last Decade

Mi‐Hyeon You

19 papers receiving 561 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mi‐Hyeon You 293 98 92 77 65 21 569
Ryan R. Gordon 229 0.8× 68 0.7× 198 2.2× 94 1.2× 45 0.7× 17 642
Matthew P. Wagoner 397 1.4× 23 0.2× 85 0.9× 97 1.3× 89 1.4× 21 756
Dmitry Sakharov 254 0.9× 37 0.4× 603 6.6× 60 0.8× 128 2.0× 15 929
Lifeng Lao 435 1.5× 56 0.6× 51 0.6× 73 0.9× 69 1.1× 30 789
Nina Hagemann 375 1.3× 48 0.5× 56 0.6× 63 0.8× 29 0.4× 27 773
Qiang Cai 320 1.1× 75 0.8× 96 1.0× 35 0.5× 98 1.5× 56 792
Junko Sawada 380 1.3× 60 0.6× 44 0.5× 144 1.9× 143 2.2× 24 989
Yuemin Ding 355 1.2× 184 1.9× 63 0.7× 34 0.4× 79 1.2× 29 722
Anastasia Tsingotjidou 242 0.8× 51 0.5× 41 0.4× 53 0.7× 109 1.7× 44 652
Lianhong Jin 363 1.2× 74 0.8× 31 0.3× 96 1.2× 127 2.0× 39 809

Countries citing papers authored by Mi‐Hyeon You

Since Specialization
Citations

This map shows the geographic impact of Mi‐Hyeon You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi‐Hyeon You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi‐Hyeon You more than expected).

Fields of papers citing papers by Mi‐Hyeon You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi‐Hyeon You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi‐Hyeon You. The network helps show where Mi‐Hyeon You may publish in the future.

Co-authorship network of co-authors of Mi‐Hyeon You

This figure shows the co-authorship network connecting the top 25 collaborators of Mi‐Hyeon You. A scholar is included among the top collaborators of Mi‐Hyeon You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi‐Hyeon You. Mi‐Hyeon You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
You, Mi‐Hyeon. (2024). Mechanism of DAPK1 for Regulating Cancer Stem Cells in Thyroid Cancer. Current Issues in Molecular Biology. 46(7). 7086–7096. 1 indexed citations
2.
Kwon, Hyemi, Mi‐Hyeon You, Tae Yong Kim, et al.. (2022). Effects of dabrafenib and erlotinib combination treatment on anaplastic thyroid carcinoma. Endocrine Related Cancer. 29(6). 307–319. 11 indexed citations
3.
You, Mi‐Hyeon, Woo Kyung Lee, Meihua Jin, et al.. (2021). Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers. Cells. 10(11). 2994–2994. 8 indexed citations
4.
You, Mi‐Hyeon, Min Ji Jeon, Woo Kyung Lee, et al.. (2021). Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression. Scientific Reports. 11(1). 2054–2054. 22 indexed citations
5.
Jin, Meihua, Woo Kyung Lee, Mi‐Hyeon You, et al.. (2021). SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer. Endocrine Connections. 10(6). 630–636. 13 indexed citations
6.
Jeon, Min Ji, Mi‐Hyeon You, Ji Min Han, et al.. (2020). High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer. Thyroid. 30(11). 1625–1638. 25 indexed citations
7.
Jeon, Min Ji, Mi‐Hyeon You, Yangsoon Park, et al.. (2019). The role of Slit2 as a tumor suppressor in thyroid cancer. Molecular and Cellular Endocrinology. 483. 87–96. 20 indexed citations
8.
You, Mi‐Hyeon, Min Ji Jeon, Tae Yong Kim, et al.. (2019). Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells. Endocrinology and Metabolism. 34(2). 203–203. 6 indexed citations
9.
Kim, Byeong Mo, Mi‐Hyeon You, Chun-Hau Chen, et al.. (2016). Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein. Human Molecular Genetics. 25(12). ddw114–ddw114. 43 indexed citations
10.
Lee, Tae Ho, Sungha Park, Mi‐Hyeon You, et al.. (2015). A potential therapeutic effect of saikosaponin C as a novel dual‐target anti‐Alzheimer agent. Journal of Neurochemistry. 136(6). 1232–1245. 33 indexed citations
11.
Li, Wenzong, Rukhsana Sultana, Mi‐Hyeon You, et al.. (2015). Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiology of Disease. 76. 13–23. 76 indexed citations
12.
You, Mi‐Hyeon, Min Seok Song, Seul Ki Lee, et al.. (2012). Voltage-gated K+ channels in adipogenic differentiation of bone marrow-derived human mesenchymal stem cells. Acta Pharmacologica Sinica. 34(1). 129–136. 31 indexed citations
13.
You, Mi‐Hyeon, Gye‐Hyeong Woo, Jun‐Young Kim, et al.. (2011). Nasopharyngeal Oncocytoma in a Cat. Journal of Veterinary Diagnostic Investigation. 23(2). 391–394. 4 indexed citations
14.
Kim, Suna, et al.. (2010). Renal Adenocarcinoma in a California Sea Lion (Zalophus Californianus). Journal of Veterinary Clinics. 27(3). 307–309. 2 indexed citations
15.
You, Mi‐Hyeon, Moon K. Kwak, Deok‐Ho Kim, et al.. (2010). Synergistically Enhanced Osteogenic Differentiation of Human Mesenchymal Stem Cells by Culture on Nanostructured Surfaces with Induction Media. Biomacromolecules. 11(7). 1856–1862. 99 indexed citations
16.
Yi, Na, et al.. (2009). A retrospective study of oral tumors in dogs: 44 cases (2002-2007).. Journal of Veterinary Clinics. 26(1). 36–40.
17.
You, Mi‐Hyeon, Wooyoung Shim, Gwang Lee, et al.. (2009). Cytosine deaminase‐producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model. Journal of Gastroenterology and Hepatology. 24(8). 1393–1400. 34 indexed citations
18.
You, Mi‐Hyeon, et al.. (2008). Hemangiosarcoma in a South American Sea Lion (Otaria byronia). Journal of Zoo and Wildlife Medicine. 39(1). 118–120. 3 indexed citations
19.
Bae, Il‐Hong, et al.. (2007). Genitourinary Rhabdomyosarcoma with Systemic Metastasis in a Young Dog. Veterinary Pathology. 44(4). 518–520. 27 indexed citations
20.
Bae, Il‐Hong, Mi‐Hyeon You, Jae-Hoon Kim, et al.. (2007). Retrospective study of canine cutaneous tumors in Korea. Journal of Veterinary Science. 8(3). 229–229. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026